MB
Marissa Brittenham (Chief Strategy Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Surgery Partners, Inc. (SGRY). The largest single filing was $120K of SGRY (8,785 sh × $13.70, as filed), executed Mar 6. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$120K
shares × price, as filed
Last traded
Mar 6
Filed Mar 9
Median ADV $20.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $497K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
SGRYRecent filings
SGRYSALE
Surgery Partners, Inc.
View filing →
$120K8,785 sh × $13.70
Exec Mar 6
Filed Mar 9 · 5:30 PM ET SGRYSALE Surgery Partners, Inc. View filing → $376K
14,700 sh × $25.61
Exec Feb 7 2025
Filed Feb 10 2025 · 5:30 PM ET